skip to Main Content
Let's Win, Lustgarten Foundation, and AACR logos

2022 AACR Annual Meeting Update

The 2022 AACR meeting featured pancreatic cancer research in artificial intelligence, screening and earlier detection, and vaccines.

pancreatic cancer researcher Wungki Park, M.D.

Claudin May Be the Next Big Target in Pancreatic Cancer Treatment

While immunotherapy and other targeted treatments involving monoclonal antibodies have been successful in other cancers, pancreatic cancer has been notoriously tough to target because of a lack of suitable cell surface targets to which the antibodies can bind. But a new target has been identified, and researchers are hopeful that an investigational drug that homes…

Dr. Manuel Hidalgo

COMBATing Pancreatic Cancer

Dr. Manuel Hidalgo explains the COMBAT trial, which combines immunotherapy, a checkpoint inhibitor, and chemotherapy to attack pancreatic cancer.

Back To Top